Literature DB >> 15519480

Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.

S Esposito1, S Noviello, S Leone, A Tice, G Seibold, D Nathwani, F Scaglione.   

Abstract

In order to assess how outpatient parenteral antibiotic therapy (OPAT) is managed in different countries, we analyzed the data collected in the USA, UK and Italy by the International OPAT Registry using an ad hoc Access/Excel Microsoft program. The analysis of data concerned 9826 patients in the USA, 981 in the UK and 620 in Italy. Differences were observed in several aspects of OPAT management such as the infections treated and the antibiotics utilized. The duration of therapy also differed: it was much longer in Italy (56.0 average days), than in the USA (22.5 days) and UK (19.9 days). Delivery model, delivery route and infusion devices show substantial differences. The present analysis shows that OPAT is carried out with substantial differences in different countries probably according to different programmes and guidelines adopted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519480     DOI: 10.1016/j.ijantimicag.2004.06.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  21 in total

1.  Home intravenous therapy: Accessibility for Canadian children and youth.

Authors:  Dl Moore; R Bortolussi
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

Review 2.  Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.

Authors:  Sebastiano Leone; Silvana Noviello; Silvano Esposito
Journal:  Infection       Date:  2015-09-01       Impact factor: 3.553

3.  Complicated community-acquired soft tissue infection by MRSA from porcine origin.

Authors:  Ph Declercq; D Petré; B Gordts; A Voss
Journal:  Infection       Date:  2007-10-31       Impact factor: 3.553

4.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

5.  Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study.

Authors:  D A Barr; L Semple; R A Seaton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-12       Impact factor: 3.267

Review 6.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.

Authors:  Christopher J A Duncan; David A Barr; R Andrew Seaton
Journal:  Int J Clin Pharm       Date:  2012-04-17

7.  Adverse effects of parenteral antimicrobial therapy for chronic bone infections.

Authors:  C Pulcini; T Couadau; E Bernard; A Lorthat-Jacob; T Bauer; E Cua; V Mondain; R-M Chichmanian; P Dellamonica; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-26       Impact factor: 3.267

8.  Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.

Authors:  Michael A Lane; Jonas Marschall; Susan E Beekmann; Philip M Polgreen; Ritu Banerjee; Adam L Hersh; Hilary M Babcock
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-09       Impact factor: 3.254

9.  Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey.

Authors:  E G Muldoon; G M Allison; D Gallagher; D R Snydman; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-01       Impact factor: 3.267

10.  Safety and efficacy of long-term outpatient ertapenem therapy.

Authors:  Zubair A Qureshi; Alveena Syed; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.